Total Funding
32
72
Total FundingFunding Round raised
Growth Score
-26 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
128062
SignalRx is a clinical-stage company that focuses on the development of effective anticancer treatments inducing the immune system.
- Durden Donald: Scientific Advisor and Founder
Matt Williams: Chief Executive OfficerPast Role: Yoss LLP, Partner
About the Company
SignalRx is a clinical-stage company that focuses on the development of effective anticancer treatments inducing the immune system. The company pursues unique programs that target the combined inhibition of key pathways involved in cancer proliferation, metastasis, angiogenesis as well as immuno-oncology.
